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Purpose: To determine the contribution of conjunctival mast cells to the allergen-specific inflammatory responses in eyes
with allergic conjunctivitis and to test the hypothesis that mast cells act as mediators of the early phase response.
Methods: The participation of mast cells in allergen-induced inflammatory cell recruitment was studied in an experimental
murine model of allergic conjunctivitis. Experimental allergic conjunctivitis was induced by a single or multiple sensitizing
injections of an allergen. The conjunctiva of allergen-sensitized, mast cell-deficient (Kitw/Kitw-v) mice were reconstituted
with conjunctival mast cells isolated from naïve wild type mice by subconjunctival transfer. Kitw/Kitw-v mice and
conjunctival mast cell reconstituted Kitw/Kitw-v mice were evaluated for early phase reactions and late phase inflammatory
responses.
Results: The early phase response was minimal in Kitw/Kitw-v mice after both a single injection and multiple sensitization
injections of the allergen. The early phase responses were fully restored following adoptive transfer of isolated conjunctival
mast cells from naïve wild type mice. Eosinophilic inflammatory responses were significantly depressed in Kitw/Kitw-v
mice without the impairment of allergen-specific priming. Reconstitution of the conjunctiva of Kitw/Kitw-v mice with mast
cells from wild type mice fully restored the allergen-specific eosinophilic responses but not the neutrophilic responses.
Conclusions: Our data indicate that conjunctival mast cells are essential for eosinophilic inflammation but not for
neutrophilia in allergic conjunctivitis that is mediated by mast cell activation.
Allergic diseases affect approximately one-third of the
population  and  constitute  one  of  the  major  health  care
problems  in  the  Western  world  [1].  Ocular  allergy  is  an
example  of  an  IgE-mediated  immediate  hypersensitivity
reaction. These reactions are initiated by the cross-linking of
IgE by an allergen, and their effects are mediated by the
degranulation  of  mast  cells.  Immediate  hypersensitivity
reactions  are  characterized  by  early  phase  and  late  phase
responses. The early phase response develops immediately
after the exposure to the allergen, and clinical symptoms and
signs  such  as  itching,  chemosis,  and  congestion  are
manifested very quickly. This is followed by the late phase
response after 8-24 h, which is characterized by conjunctival
eosinophilia and neutrophilia.
Eosinophilic  inflammation  is  not  only  a  hallmark  of
allergic conjunctivitis but also a major cause for tissue injury
and remodeling. Therefore, to understand how this response
develops  or  is  exacerbated  is  important  in  developing  an
effective strategy to combat ocular allergy.
The  role  played  by  T  cells  in  the  eosinophilic
inflammation  of  severe  allergic  conjunctivitis  has  been
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gaining interest. For example, we have reported that the potent
inhibitor  of  T  cell  activation,  tacrolimus,  will  reduce  the
symptoms and signs of a severe form of allergic conjunctivitis
involving a corneal ulcer [2]. In experimental settings, an
eosinophil infiltration can occur independent of the presence
of mast cells [3,4]. Thus, the question arises as to how mast
cells contribute to ocular inflammatory cell recruitment. Are
conjunctival mast cells simply serving to induce the clinical
symptoms during the early phase and play a subordinate part
in the final late phase inflammatory process?
To answer this question and to evaluate the contribution
of mast cells to the late phase inflammatory process, we have
developed a mast cell reconstituted model. Bone marrow-
derived mast cells (BMMCs) are commonly used to restore
mast  cell  populations.  However,  these  cells  are  not
appropriate  for  the  analyses  of  ocular  responses  because
BMMCs have a distinct lineage from mast cells in connective
tissues such as those residing in the conjunctiva [5]. Indeed,
important maturation markers of connective tissue type mast
cells such as CCR3, a receptor of eotaxin-1, are not expressed
by BMMCs [5]. For inflammatory responses, mast cells are
recruited to the effector site from the bone marrow, and they
mature  in  situ  presumably  by  differentiating  into  an
inflammatory  phenotype  by  chemokine  receptors.  Thus,
conjunctival allergic responses are mixed phenomena induced
by tissue-residing mast cells and newly recruited mast cells.
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1525We have developed an adoptive transfer model in which
the conjunctiva of mast cell-deficient mice is reconstituted
with conjunctival mast cells from wild type mice. After the
induction  of  allergen-specific  allergic  conjunctivitis,  we
carefully assessed the contribution of mast cells to the early
phase and late phase responses.
METHODS
Animals:  Mast  cell-deficient  mice  were  of  the  Kitw/Kitw-v
strain. c-Kit is a protein that is essential for the development
and activation of mast cell lineage cells. Kitw/Kitw-v mice carry
point mutations in the transmembrane and kinase domains and
therefore lack the ability to activate the signaling cascade
initiated by its ligand, stem cell factor (SCF). The mast cell
deficiency is greater than 99% in the systemic circulation,
airway, intestine, and skin of these mice [6]. The mast cell-
deficient WBB6F1-Kitw/Kitw-v (Kitw/Kitw-v) mice and congenic
wild-type (WBB6F1
+/+) mice were purchased from Shimizu
Laboratories Supplies (Kyoto, Japan). The wild type mice
were  age-matched  and  gender-matched  and  reared  under
identical conditions as the mast cell-deficient Kitw/Kitw-v mice.
The procedures used conformed to all of the regulations for
laboratory animal research outlined by the Animal Welfare
Act, the Department of Health, Education, and Welfare (NIH)
guidelines, and the ARVO statement for the experimental use
of animals.
Immunization  and  induction  of  experimental  allergic
conjunctivitis: Kitw/Kitw-v and wild type mice were allergen-
sensitized using protocols developed in our laboratory [7-9].
We used two established immunization protocols; one used a
single exposure and the other using multiple exposures [7-9].
In both models, the inflammatory cell recruitment in the late
phase is dependent on mast cell degranulation.
For the single exposure protocol [8], anesthetized mice
were injected with a suspension of 50 μg of ragweed pollen
(ICN, Aurora, OH) and 1 mg of aluminum hydroxide (Sigma,
St.  Louis,  MO)  into  the  left  hind  footpad.  On  day  22,
conjunctivitis was induced by topical application of 1.5 mg of
ragweed suspended in 10 μl of phosphate buffered saline
(PBS). Control mice were mock-sensitized with aluminum
hydroxide  and  challenged  identically  with  the  ragweed
suspension.
The  clinical  responses  were  graded  using  a  modified
version of our published method 20 min after the allergen
challenge  [7-9].  Conjunctival  edema,  lid  edema,  tear/
discharge, and conjunctival redness were graded from 0 to 4
by an observer who was masked to the treatment protocol of
the  mice  (Table  1).  The  cumulative  clinical  score  was
calculated  as  the  sum  of  the  scores  of  each  of  the  four
parameters with a range from 0 to 16.
For the repeated exposure protocol, groups of mice (10
mice per group) were initially injected intraperitoneally with
1 mg of aluminum hydroxide that was conjugated with cat
dander  extract  (200  BAU/mouse;  ALK  Laboratories,
Horsholm, Denmark) on days 1, 14, and 24. Control mice were
injected with the vehicle of the dander extract on the same
days.  Concomitantly,  aluminum  hydroxide  (25  μg/eye)-
conjugated cat dander extract (10,000 BAU/ml) or vehicle
was applied topically to the eye on days 1, 2, 3, 7, and 14.
Thereafter, mice were exposed to the allergen for sensitization
once  a  week  by  topical  instillation  of  cat  dander  extract
(10,000 BAU/ml) or vehicle onto the eye. Eight weeks after
the initial sensitization, affinity-purified Fel d 1 (0.5 mg/ml),
cat  dander  extract  (10,000  BAU/ml;  Greer  Laboratories,
Lenoir, NC), or vehicle was applied to the eyes (10 μl /eye)
for two consecutive days for the final priming. The early phase
and late phase responses were elicited by instilling cat hair
allergen (Fel d 1) to all mice 24 h after the last allergen
sensitization.
For histological evaluation, mice were sacrificed 2 h after
the challenge to investigate the early phase response and 24 h
after the challenge to examine the late phase inflammatory
response.  The  tissues  from  the  eyes  were  fixed  in  4%
paraformaldehyde  and  embedded  in  HistoResin  (Leica
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TABLE 1. GRADING CRITERIA OF CLINICAL SCORES.
Criteria 0 1 2 3 4
conjunctival edema none focal edema edema confined
within one quadrant
edema extending to 3
quadrants
massive edema.
lid edema none slightly narrowed palpebral
fissure (3/4 normal width)
with congestionsevere edema
(1/3 of normal width)
narrowed palpebral
fissure with edema
(2/3 of normal width)
narrowed fissure with
severe edema (1/3 of
normal width)
massive edema
(cornea barely visible).
tear/discharge minimal level of
                                        tear meniscus
increased tear level with
concave meniscus
increased tear level
with convex meniscus
highly increased tear
level with mucous
secretion
excessive tearing with
copious discharge
conjunctival redness none barely detectable venous
dilatation
three or four dilated
vessels at corneal
limbus
five or six dilated
vessels at limbus
marked ciliary
injection
The clinical responses were graded at 20 min after allergen challenge.Instruments  GmbH,  Heidelberg,  Germany).  Serial  sagittal
sections (3 μm thick) were cut and stained with toluidine blue,
Giemsa, or hematoxylin and eosin. Three serial sections of the
conjunctival tissue were examined from each eye to determine
the  number  of  inflammatory  cells  recruited  into  the
conjunctiva. A masked observer counted the number of cells
under a 400X microscopic field.
Measurement of allergen-specific IgE and IgG1 antibodies:
Sera were collected by cardiac puncture 24 h after the allergen
challenge. The Fel d 1-specific IgE and IgG1 levels were
measured by ELISA [9,10]. The sera were pipetted onto a Fel
d  1-coated  microtiter  plate  (Maxisorp;  Nalge  Nunc
International  KK,  Tokyo,  Japan),  incubated  with  biotin-
conjugated anti-IgE (BD Biosciences, Franklin Lakes, NJ) or
anti-IgG1  (SouthernBiotech,  Birmingham,  AL)  antibodies,
and developed for peroxidase-based substrate detection.
Isolation  and  FACS  analysis  of  mast  cells  from  the
conjunctiva: The protocol to isolate crude conjunctival mast
cells was developed and optimized based on an enzymatic
digestion method. Briefly, the conjunctiva of eight-week-old
to 12-week-old SWR/J mice were cut into fragments and
incubated  in  RPMI1640  medium  supplemented  with  10%
fetal bovine serum, 1.5 mg/ml collagenase (Nitta Gelatin,
Osaka, Japan), 0.5 mg/ml hyaluronidase (Sigma), and 0.5 mg/
ml DNase I (Sigma) for 2 h at 37 °C. The dispersed cells were
filtered through a 40 μm cell strainer, layered on an isotonic
Percoll  density  medium  (density=1.041,  Amersham
Pharmacia Biotech, Piscataway, NJ), and centrifuged at 800x
g for 20 min [11]. The pellet was cultured in RPMI1640 with
murine recombinant IL-3 (10 ng/ml; Peprotech, Rocky Hill,
NJ), recombinant SCF (10 ng/ml; Peprotech), and 5% serum
for two days. Colony-forming, non-adherent mast cells were
harvested by gentle shaking and decanting of the flasks. The
cells  were  then  layered  onto  a  Percoll  density  medium
(density=1.041) and centrifuged at 800x g for 20 min.
To precisely evaluate the roles of mast cells, a further
purification  protocol  was  developed  for  the  functional
analyses. Based on preliminary FACS analyses, contaminated
populations  included  dendritic  cells,  macrophages,  and
plasma cells, which were characterized by the expression of
CD4, CD8a, CD11b, B220, and PDCA-1. These markers were
selected  and  confirmed  for  appropriateness  for  depletion
markers  based  on  the  co-expression  of  mature  mast  cell
markers such as CCR3 and CXCR3 (data not shown). To
deplete  these  cells,  we  used  a  magnet–based  negative
depletion method to obtain maximum recovery. Briefly, cells
were blocked by anti-CD32 (Clone 93; eBiosciences, San
Diego, CA) and labeled with rat anti-CD4, rat anti-CD8a, rat
anti-CD11b, rat anti-B220 (all from eBiosciences), and rat
anti-PDCA-1 (Miltenyi Biotec Inc., Auburn, CA). The labeled
fractions were depleted using anti-rat immunoglobulin κ chain
antibody-conjugated microbeads (IMag; BD Biosciences).
For FACS analyses, cultured mast cells were blocked by
anti-CD32 and stained for immunofluorescence analysis. The
analysis  was  performed  with  the  FACSCalibur  flow
cytometer  (Becton  Dickinson,  Franklin  Lakes,  NJ).
Phycoerythrin (PE)-conjugated anti-CXCR3 antibody (R&D
Systems,  Minneapolis,  MN),  biotin-conjugated  anti-c-Kit
antibody  (2B8;  eBiosciences),  PE-conjugated  anti-c-Kit
antibody  (eBiosciences),  FITC-conjugated-anti-FcεRI  α
subunit (MAR-1, eBiosciences), and Peridinin-chlorophyll-
protein  (PerCP)-conjugated  streptavidin  (BD  Biosciences)
were used for staining the mast cells. FITC-conjugated IgG
(eBiosciences), PE-conjugated IgG (eBiosciences), PerCP-
conjugated IgG (BD Biosciences), and biotin-conjugated IgG
(eBiosciences) were used for isotype control staining.
Adoptive transfer of isolated conjunctival mast cells: Purified
mast cells (4×105 cells/eye) from wild type mice were injected
subconjunctivally into allergen-sensitized, mast cell-deficient
Kitw/Kitw-v mice. Immediate hypersensitivity was induced by
allergen exposure two weeks after the transfer. Connective
tissue type mast cells were identified in the recipient mice and
control  wild  type  mice  by  measuring  the  conjunctival
transcripts of mMCP-5, mMCP-6, and FcεRI α subunit by
quantitative reverse transcription polymerase chain reaction
(RT–PCR) and Giemsa staining.
Statistical  analyses:  Data  are  presented  as  the  means
±standard error of the means (SEMs). Statistical analyses
were performed by ANOVA.
RESULTS
Mast  cells  required  for  early  phase  response  of  allergic
conjunctivitis: We first examined whether the tissues on the
ocular surface of Kitw/Kitw-v mice had any mature mast cells
that could be identified by the presence of metachromatic
granules. An earlier investigation showed that mast cells were
not present in different mucosal tissues of these mice [6], and
in confirmation, we found that mast cells were absent in the
conjunctiva, eyelids, and choroid of naïve Kitw/Kitw-v mice.
To evaluate the contribution of mast cells to the ocular
symptoms  during  the  early  phase  allergic  response,  we
challenged sensitized mice with the allergen following the
single  exposure  protocol.  Mice  were  assessed  for  clinical
signs  including  conjunctival  edema,  conjunctival  redness,
tearing, and lid edema. The degree of inflammation during the
early phase is summarized as clinical scores in Figure 1A. The
clinical scores for both sensitized and mock-sensitized Kitw/
Kitw-v mice were significantly lower following the allergen
challenge than that of wild type mice (sensitized wild type:
8.7±0.3, sensitized Kitw/Kitw-v: 1.8±0.7, p<0.05). The clinical
scores  for  Kitw/Kitw-v  mice  appeared  not  specific  for  the
allergen  because  no  significant  difference  was  observed
between  the  sensitized  and  mock-sensitized  mice.  This  is
consistent  with  the  concept  that  conjunctival  mast  cells
mediate the clinical signs after the allergen challenge.
To examine the contribution of mast cells to the clinical
signs in allergic inflammation in more detail, we restored
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1527Figure 1. Effect of adoptive transfer of
mast cells isolated from wild type mice
to  mast  cell-deficient  mice  on  the
clinical  responses  in  the  acute  phase.
A: Recovery of defective acute phase
clinical  responses  in  Kitw/Kitw-v  mice
after adoptive subconjunctival transfer
of  conjunctival  mast  cells  from  wild
type cells is shown. The clinical scores
for both sensitized and mock-sensitized
Kitw/Kitw-v  mice  were  significantly
lower following allergen challenge than
that  of  wild  type  mice.  B:  Allergen-
induced-mast cell degranulation in Kitw/
Kitw-v  mice  after  adoptive  transfer  of
conjunctival mast cells from wild type
mice is demonstrated in the chart. Mast
cell  degranulation  in  the  conjunctiva,
undetectable  in  Kitw/Kitw-v  mice,  was
observed in both sensitized and mock-
sensitized  adoptive  transfer  mice.  C:
Expression  of  mast  cell-restricted
proteases,  mMCP-5  and  mMCP-6,  in
the conjunctiva of Kitw/Kitw-v mice after
adoptive  transfer  is  shown.  Mice
injected with the conjunctival mast cells
had  levels  of  mMCP-5  and  mMCP-6
that were comparable to those of wild
type mice. D: Expression of CXCR3 as
a  maturation  marker  on  conjunctiva-
derived  FcεRI+  c-Kit+  mast  cells  by
FACS  analysis  is  demonstrated.  Red
indicates  the  CXCR3  stained
conjunctiva-derived  mast  cells.  Black
shows  the  isotype  control.  RW:
sensitized  with  ragweed  pollen;  PBS:
mock sensitized; n=10 mice/group.
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mice. Conjunctival mast cells, isolated by lineage marker
depletion after density-gradient separation, were tested for
allergen-induced  degranulation  and  mast  cell-restricted
proteases. The conjunctiva-derived mast cells expressed high
levels  of  the  connective  tissue  type  mast  cell  proteases,
mMCP-5, mMCP-6, and mMCP-7. When these cells were
sensitized with anti-DNP-specific IgE and exposed to DNP-
albumin,  they  appropriately  degranulated  in  an  allergen-
specific manner (data not shown).
Peripheral  tissues,  including  the  conjunctiva,  are
continuously replenished by the migration of bone marrow-
derived mast cells. To exclude any effect of newly immigrated
cells from the bone marrow, the conjunctiva of mast cell-
deficient  mice  were  reconstituted  with  the  conjunctiva-
derived mast cells from the wild type mice.
The conjunctival mast cells that were expressing CXCR3
as a maturation marker of conjunctival mast cells (Figure 1D)
[5] and isolated from naive wild type mice were adoptively
transferred  into  the  allergen-sensitized  Kitw/Kitw-v  mice  by
subconjunctival  injection.  Conjunctival  expression  of  the
mast cell restricted transcripts, mMCP-5 and mMCP-6, was
used  to  assess  the  success  of  the  transfer.  As  expected,
mMCP-5 and mMCP-6 were not expressed at appreciable
levels in the conjunctiva of Kitw/Kitw-v mice (Figure 1C). In
contrast, mice injected with the conjunctival mast cells had
levels of mMCP-5 and mMCP-6 that were comparable to
those of wild type mice (Figure 1C). This confirmed that the
transferred  mast  cells  maintained  the  properties  of  the
connective tissue type as conjunctival mast cells.
To examine their homing ability, real time PCR was
conducted to examine levels of mast cell-specific proteases in
the  draining  lymph  nodes  of  the  adoptive  transfer  mice.
Neither mMCP-5 nor mMCP-6 was detected in the adoptive
transfer mice (below detection limits). This indicated that the
transferred mast cells remained in the conjunctiva and did not
migrate elsewhere.
When  the  adoptive,  transferred  Kitw/Kitw-v  mice  were
challenged  with  an  allergen,  clinical  signs  of  allergic
inflammation  were  restored  (Figure  1A).  Mast  cell
degranulation in the conjunctiva, undetectable in Kitw/Kitw-v
mice, was observed in both sensitized and mock-sensitized
adoptive transfer mice. The sensitized mice had significantly
more allergen-specific mast cell degranulation than the mock-
sensitized mice (53% versus 17%, p<0.05; Figure 1B). The
restored response was indistinguishable from that of the wild
type mouse response, supporting the validity of our adoptive
transfer model using Kitw/Kitw-v mice with conjunctival mast
cells.
We have shown that the degree of mast cell degranulation
is  linearly  correlated  with  the  clinical  scores  [9].  Thus,
conjunctival  mast  cells  are  necessary  and  sufficient  for
activation of the acute phase clinical responses.
In clinical settings, allergic symptoms are provoked after
repeated  exposure  to  an  allergen.  We  have  shown  that
repeated exposure to an allergen aggravated the clinical signs
and altered mast cell restricted proteases [12]. Therefore, we
tested  whether  repeated  allergic  exposure  could  stimulate
mast cell recruitment or maturation to correct the conjunctival
mast cell deficiency in Kitw/Kitw-v mice. Our results showed
that even after repeated allergen exposures, conjunctival mast
cells were not detected in sensitized Kitw/Kitw-v mice. The
clinical scores were also significantly lower in the sensitized
mast cell-deficient mice than in sensitized wild type mice
following  multiple  allergen  exposures,  (1.8  versus  10.5,
p<0.05;  Figure  2).  The  clinical  signs  were  completely
suppressed, and the tear/discharge score was depressed by
78%.
To  determine  whether  mast  cell  deficiency  affected
antigen-specific B cell and T cell responses during allergic
conjunctivitis, levels of allergen-specific IgE and IgG1 were
measured after the final allergen challenge. The titers of IgE
and IgG reflect the function of both B cells and T cells because
an increased production of IgE and IgG1 requires numerous B
cell  and  T  cell  processes  including  antigen  presentation,
antigen-specific T cell expansion, class switch recombination
of B cells, and specific antibody production.
Allergen-specific  IgE  and  IgG1  were  appropriately
induced following the allergen challenge in sensitized wild
type mice but not in mock-sensitized wild type mice (Figure
3).  Levels  of  allergen-specific  IgE  and  IgG1  were  not
significantly different between Kitw/Kitw-v mice and wild type
mice, indicating that the inductive arm of Kitw/Kitw-v mice was
still functioning normally during the sensitization phase.
Requirement of mast cells for late phase response of allergic
conjunctivitis: We evaluated the dependency of the late phase
Figure 2. Abolishment of early phase clinical symptoms in mast cell-
deficient mice. The clinical scores were also significantly lower in
the sensitized mast cell-deficient mice than in sensitized wild type
mice following multiple allergen exposures. An asterisk indicates
that p<0.005. Fel d 1: sensitized with Fel d 1; PBS: mock-sensitized;
n=10 mice/group.
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recruitment  of  inflammatory  cells  24  h  after  the  allergen
challenge. To exclude the possible effects of preconditioning
by  repeated  exposures,  we  first  used  the  single  exposure
protocol  for  sensitization.  Allergen-specific,  late  phase
responses in wild type mice were characterized mainly by
conjunctival infiltration of eosinophils. Foci of inflammatory
cells were accompanied or surrounded by mast cells, implying
some role for the mast cells in this process (Figure 4A). No
increase  in  conjunctival  infiltration  of  eosinophils  and
neutrophils was observed in sensitized Kitw/Kitw-v mice 24 h
after  the  allergen  challenge  (Figure  4B).  However,  when
conjunctival mast cells were transferred to sensitized Kitw/
Kitw-v mice, the allergen-specific eosinophil recruitment in the
transferred mice was completely restored (Figure 4B). These
observations  clearly  demonstrated  that  the  late  phase
eosinophil  infiltration  is  dependent  on  mast  cell  activity.
Interestingly, we did not observe an increase in neutrophil
recruitment in any of the sensitized animals compared to their
mock-sensitized counterparts (Figure 4B).
We  next  sensitized  mice  using  the  repeated  allergen
exposure model [9] and then evaluated mast cell contributions
to the local activation or preconditioning of bystander cells or
mast  cells.  In  wild  type  mice,  an  allergen  challenge
significantly increased the number of conjunctival eosinophils
in  the  sensitized  animals  but  not  in  the  mock-sensitized
animals  (Figure  5).  However,  the  number  of  conjunctival
eosinophils was not significantly increased in sensitized Kitw/
Kitw-v mice (Figure 5B). The conjunctival eosinophil count
following allergen exposure was significantly lower in Kitw/
Kitw-v mice than in wild type mice (19.1 versus 9.0, p<0.005),
although there was no significant difference in the number of
eosinophils between the mock-sensitized wild type and Kitw/
Kitw-v mice. All changes in the neutrophil count following the
allergen challenge were not significant (Figure 5B).
Taken together, the data from the adoptive transfer model
have  shown  that  conjunctival  mast  cells  are  essential  for
eosinophil  recruitment  in  the  early  phase  and  late  phase
Figure 3. Induction of Fel d1-specific IgE and IgG1 in Kitw/Kitw-v
mice. Kitw/Kitw-v mice are not impaired for Fel d 1-specific IgE or
IgG1. Fel d 1: sensitized with Fel d 1; PBS: mock-sensitized; n=10
mice/group.
allergic responses in the eye but not essential for neutrophil
recruitment.
DISCUSSION
Our  results  demonstrated  important  aspects  of  mast  cell
involvement in ocular allergy (i.e., the activation of locally
residing conjunctival mast cells) after an allergen exposure
induced the recruitment of eosinophils. This is in marked
contrast to the conclusions of Ueta et al. [4] who reported that
mast cells were not required for eosinophil recruitment in
allergic  conjunctivitis  using  antigen-sensitized,  mast  cell-
deficient mice. However, their conclusion considered only
one aspect of allergic conjunctivitis. It is known that allergic
conjunctivitis  is  triggered  by  the  mast  cell  degranulation-
mediated cascade, and this needs to be clearly shown in the
model being evaluated for mast cell dependence. However,
eosinophilia  is  a  good  indicator  of  allergic  conjunctivitis.
Indeed,  the  mast  cell-mediated  activation,  which  was  not
presented in their report, primes Th2-type T cells-dependent
eosiophil recruitment. For example, the transfer of Th2-type
T cells can induce massive eosinophilic inflammation. Also,
in the corneal transplantation model, inflammatory responses
Figure 4. Impairment of late phase inflammatory responses in Kitw/
Kitw-v mice and subsequent response recovery in Kitw/Kitw-v mouse
recipients  of  conjunctival  mast  cells.  A:  Kitw/Kitw-v  mice,
subconjunctivally injected with wild type conjunctival mast cells,
were  challenged  with  an  allergen,  and  the  conjunctiva  were
processed for Giemsa staining after 24 h. The left image shows
conjunctiva of mock-sensitized Kitw/Kitw-v adoptive transfer mice.
The right image shows conjunctiva of allergen-sensitized Kitw/Kitw-
v adoptive transfer mice. Each asterisk in the images denotes the
presence of eosinophils, and an arrow indicates transferred mast
cells. B: Recovery of defective eosinophil recruitment in Kitw/Kitw-
v mice by subconjunctival adoptive transfer of conjunctival mast cells
from wild type mice is shown in the chart. The sharp (hash mark)
means that p<0.05. RW: sensitized with ragweed pollen; PBS: mock
sensitized; n=10 mice/group.
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combinations [13]. Thus, one can create experimental settings
where  the  involvement  of  mast  cells  is  least  required.
Evaluation  of  eosinophilic  inflammation  in  allergic
conjunctivitis needs to be evaluated by the activation of mast
cells.
We  do  not  argue  that  eosinophilia  can  occur  with  a
minimal activation of mast cells. This situation can be created
by repetitive and strong immunizations. Ueta et al. [4] used
an  intradermal  injection  of  ragweed  allergen  followed  by
multiple boosting by two intraperitoneal injections and four
repetitive allergen exposures. This would usually result in a
vigorous T cell-mediated response and clonal expansion that
should culminate in a massive eosinophil recruitment after an
antigen challenge [3,14,15]. In addition, they claimed that the
attenuated protocol (one intradermal injection followed by
one intraperitoneal injection) still provoked allergen-induced
eosinophil recruitment in mast cell-deficient mice. However,
this model also appeared to be independent of IgE-mediated
mast cell degranulation because no allergen-specific IgE was
detected in the sera of their experimental mice.
Figure 5. Impairment of late phase inflammatory responses in Kitw/
Kitw-v mice. A: Kitw/Kitw-v mice were challenged with an allergen,
and the conjunctiva were processed for Giemsa staining after 24 h.
The asterisk in the image denotes mast cells, and an arrow denotes
the presence of eosinophils. 400X magnification. B: Recruitment of
eosinophils and neutrophils in the conjunctiva of Kitw/Kitw-v mice is
show in the chart. The sharp (hash mark) denotes that p<0.005 and
the double sharp denotes that p<0.05. Fel d1: sensitized with Fel d1;
PBS: mock sensitized; n=10 mice/group.
The  contribution  of  mast  cells  to  the  eosinophilic
responses can be explained by the properties of the cytokines
and  chemokines  released  upon  activation.  For  example,
conjunctival mast cells activated by FcεRI produce IL-2, IL-3,
IL-4, IL-5, IL-6, IL-10, IL-12, GM-CSF, MIP-1α, and TNF-
α (unpublished observations). IL-3 and IL-5 are particularly
likely to contribute to eosinophilic inflammation as they play
critical  roles  in  eosinophil  development,  survival,  and
recruitment [16]. Other mast cell-derived mediators that might
contribute to eosinophil activity in ocular hypersensitivity
include the leukotrienes, B4 and D4, and tryptases [17,18].
These observations are consistent with the idea that T cell
priming  is  required  for  mast  cell-related  eosinophilia  and
support our findings that mast cells mediated the eosinophil
recruitment in the late phase inflammation.
It has been suggested that the role of conjunctival mast
cells was to induce neutrophilic inflammation. For example,
when mast cell degranulation is induced in the conjunctiva by
compound 48/80, the resulting conjunctivitis is characterized
by  infiltration  of  neutrophils,  macrophages,  and  CD4+  T
lymphocytes but surprisingly few eosinophils [19]. This is in
marked  contrast  to  our  observations,  which  showed  that
neutrophilic inflammation does not require conjunctival mast
cells.  This  might  be  due  to  the  relative  low  levels  of
neutrophilic cytokines derived from mature mast cells. The
mononuclear cells and macrophages are the major sources of
neutrophilic  cytokines  such  as  TNF-α  and  MIP-1α.  We
suggest  that  the  neutrophilic  inflammation  induced  by
compound 48/80 may be explained by such mediators derived
from  mononuclear  cells  and  macrophages,  which  are
indirectly  stimulated  by  mast  cell-derived  chemokines  or
cytokines.
In conclusion, our new mast cell reconstituted model is a
better method to investigate what role conjunctiva-residing
mast cells play in experimental allergic conjunctivitis. This
allowed us to evaluate the direct contribution of mast cells to
eosinophilic  inflammation.  Our  data  support  the  idea  that
regulation of mast cell activation and maturation in addition
to current therapy to suppress mast cell degranulation might
be promising therapeutic strategies. Direct targeting of c-Kit,
mast cell-derived chemokines, or chemokine receptors might
also yield good therapeutic results [9,20-22].
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